Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Joel Weinthal"'
Publikováno v:
Transplantation and Cellular Therapy. 29:S422-S423
Publikováno v:
Blood. 140:12675-12676
Autor:
Mitchell S. Cairo, Carmella van de Ven, Sharon Bergeron, Joel Weinthal, Gregory H. Reaman, Leslie Garrison, Bruce R. Blazar, Mark Krailo, Rita Secola
Publikováno v:
Cancer. 83:1449-1460
BACKGROUND This Phase I trial was developed to determine the safety, biologic activity, and effects on hematopoietic recovery of PIXY321 following ifosfamide, carboplatin, and etoposide chemotherapy for children with recurrent or refractory solid tum
Autor:
Mitchell Cairo, Bruce Bostrom, Carole G. Hurvitz, Victor M. Santana, Joel Weinthal, Thomas J. Moss
Publikováno v:
Blood. 83:3085-3089
Peripheral blood stem cells (PBSCs) are being used as an alternative to autologous marrow rescue for hematopoietic reconstitution after high- dose chemotherapy in patients with neuroblastoma and other solid malignancies. Use of PBSCs is preferred by
Autor:
Donald B. Kohn, Jan A. Nolta, Joel Weinthal, Ingrid Bahner, Xiao Jin Yu, James Lilley, Gay M. Crooks
Publikováno v:
Human Gene Therapy. 2:101-105
We are studying the transfer and expression by retroviral vectors of the human glucocerebrosidase (GC) gene into bone marrow cells as a model of gene therapy for genetic diseases of hematopoietic cells. A simple retroviral vector (G2) was developed t
Autor:
Kenneth Cornetta, Joel Weinthal, Philip L. McCarthy, Donna A. Wall, Colleen Delaney, Nelson J. Chao, Robert Sweetman, Shelly L. Carter, Mary J. Laughlin, John E. Wagner
Publikováno v:
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 11(2)
The Cord Blood Transplantation study group conducted a prospective study of unrelated cord blood transplantation (CBT) to better define the role of this stem cell source for subjects requiring unrelated allogeneic transplantation. We report on 1 stra
Autor:
Jeffrey A. Fearon, Joel Weinthal
Publikováno v:
Plastic and reconstructive surgery. 109(7)
The vast majority of infants and children undergoing craniosynostosis correction receive a blood transfusion. The risks of blood transfusion include, but are not limited to, acute hemolytic reactions (approximately 1 of 250,000), human immunodeficien
Autor:
Jeffrey A. Fearon, Joel Weinthal
Publikováno v:
Plastic and Reconstructive Surgery. 112:1732-1733
Autor:
Joel Weinthal, Jeffrey A. Fearon
Publikováno v:
Plastic and Reconstructive Surgery. 111:2485-2486
The vast majority of infants and children undergoing craniosynostosis correction receive a blood transfusion. The risks of blood transfusion include, but are not limited to, acute hemolytic reactions (approximately 1 of 250,000), human immunodeficien
Publikováno v:
Blood. 112:4660-4660
Over the past 20 years umbilical cord blood (UCB) has become valuable source of hematopoietic stem cells for use in transplantation to treat malignancies, blood disorders and genetic diseases. Cord blood stem cells have shown promising results in ani